← All trials
NCT05030272
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 21, 2021
- Primary completion
- Oct 1, 2023
- Completion date
- Oct 1, 2023
- First posted
- Sep 1, 2021
- Last posted
- Nov 17, 2021
- Enrollment
- 450
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Duke UniversityLead sponsor
- National Institutes of Health (NIH)Collaborator
- National Institute on Drug Abuse (NIDA)Collaborator
- University at BuffaloCollaborator
- Duke UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.